CRISPR Therapeutics
Biotechnology Research
Boston, Ma, United States
385 employees
- Employees
- 385
- Contacts
- 2
- Emails
- 2
CRISPR Therapeutics Overview
- Headquarters
- Boston, Ma, United States
- Phone Number
- Available in AeroLeads
- Website
- crisprtx.com
- Industry
- Biotechnology Research
- Employees
- 385
- Founded
- 2013
- Funding
- 280.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About CRISPR Therapeutics
Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.
CRISPR Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
CRISPR Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Robert Stern | Greater Boston, United States |
View
|
|
| Megan Wherry Menner | Senior Vice President, Head of Human |
View
|
|
| Daniel Hostetter | San Francisco, California, United States |
Email
|
|
| Edd Fleming | Supporting Life Science Companies | Palo Alto, California, United States |
Email
|
Employees by Management Level
Individual contributor
10 profiles
Manager
9 profiles
Director
6 profiles
Senior / Lead
6 profiles
Executive
4 profiles
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 5 | 5 | 2 |
| Healthcare | 5 | 5 | 2 |
| IT | 5 | 5 | 0 |
| Operations | 3 | 3 | 1 |
| Executive | 1 | 1 | 1 |
| Finance | 1 | 1 | 0 |
CRISPR Therapeutics Tech Stack
Engineering
5 profiles
Data / AI
2 profiles
Compare Similar Companies to CRISPR Therapeutics
Moderna
Biotechnology Research
Vertex Pharmaceuticals
Biotechnology Research
Alnylam Pharmaceuticals
Biotechnology Research
Sarepta Therapeutics
Biotechnology Research
Beam Therapeutics
Biotechnology Research
Bluebird Bio
Biotechnology Research
Intellia Therapeutics, Inc.
Biotechnology Research
Tessera Therapeutics
Biotechnology Research
Verve Therapeutics
Biotechnology Research
Editas Medicine
Biotechnology Research